Optical probing of acetylcholine receptors on neurons in the medial habenula with a novel caged nicotine drug analogue
- J Physiol. 2018 Nov;596(22):5307-5318. doi: 10.1113/JP276615.
- 1. Department of Neuroscience, Mount Sinai School of Medicine, New York, NY, USA.
Key points: A new caged nicotinic acetylcholine receptor (nAChR) agonist was developed, ABT594, which is photolysed by one- and two-photon excitation. The caged compound is photolysed with a quantum yield of 0.20. One-photon uncaging of ABT594 elicited large currents and CA2+ transients at the soma and dendrites of medial habenula (MHb) neurons of mouse brain slices. Unexpectedly, uncaging of ABT594 also revealed highly CA2+ -permeable nAChRs on axons of MHb neurons.
Abstract: Photochemical release of neurotransmitters has been instrumental in the study of their underlying receptors, with acetylcholine being the exception due to its inaccessibility to photochemical protection. We caged a nicotinic acetylcholine receptor (nAChR) agonist, ABT594, via its secondary amine functionality. Effective photolysis could be carried out using either one- or two-photon excitation. Brief flashes (0.5-3.0 ms) of 410 nm light evoked large currents and CA2+ transients on cell bodies and dendrites of medial habenula (MHb) neurons. Unexpectedly, photorelease of ABT594 also revealed nAChR-mediated CA2+ signals along the axons of MHb neurons.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: nAChRResearch Areas: Neurological Disease